Please ensure Javascript is enabled for purposes of website accessibility
Isaac Kinde, M.D., Ph.D. Chief Scientific Officer PapGene Inc. PapGene Inc., launched in 2014 out of the Johns Hopkins University system and now is commercializing novel “genetic cytology” technologies for the improved management of cancer patients. “Our unique approach allows for the detection of a variety of cancers at early stages when patients have the highest chance of being ...